#15 – The New Category: Decentralized Clinical Trials

Share This Post

Episode Details

In this episode, we hear from our guest: Michelle Longmire, CEO & Co-Founder at Medable.

Topics discussed:
  • Michelle Longmire’s Inspiration: In medical school, Longmire recognized a critical access gap in healthcare. Training at the University of New Mexico, she observed the challenges faced by underserved patients and envisioned a technological bridge to healthcare.
  • Formation of Medable: The idea of Medable was shaped by Longmire’s experience at Stanford and the rise of mobile technology. The aim was to create a platform that provided secure, accessible healthcare and research opportunities.
  • Early Challenges and Milestones: Winning a pitch contest provided initial funding for Medable. Key hires included experts in platform technology, mobile app development, and enterprise architecture. The first major contract with a pharma company highlighted the need for expanded capabilities.
  • Role in Decentralized Clinical Trials: Longmire foresaw mobile technology as a key driver in making research consumer-scale. The focus on patient-centered research and providing better access led to the rise of decentralized clinical trials.
  • Vision for Clinical Trial Innovation: Longmire’s vision includes leveraging AI and technology to dramatically increase the number of effective therapies tested and approved each year, addressing a wide range of diseases more efficiently.

Watch

Listen

Read More

Discovering a Healthcare Access Gap

In medical school, Michelle Longmire recognized a significant healthcare access gap, especially in underserved communities. Her experiences at the University of New Mexico were instrumental in shaping her vision for a more accessible healthcare system through technology.

Birth of Medable and its Vision

Medable’s inception was a result of Longmire’s experiences and insights during her time at Stanford, combined with the emergence of mobile technology. The idea was to build a platform that not only connected patients with healthcare services but also ensured data security and privacy.

Initial Challenges and Breakthroughs

Winning a pitch contest provided the seed money for Medable. Longmire’s strategic hiring decisions, focusing on expertise in platform technology, mobile app development, and enterprise architecture, laid a solid foundation for the company. The first major pharma contract was a significant milestone, signaling the need for further expansion and capability enhancement.

Impact on Decentralized Clinical Trials

Longmire’s foresight in leveraging mobile technology played a pivotal role in shaping decentralized clinical trials. By focusing on patient-centered research and improving access, Medable became a trailblazer in this new approach to clinical research.

Future of Clinical Trial Innovation

Looking ahead, Longmire’s vision includes integrating AI and advanced technology to substantially increase the number of new therapies tested and approved annually. This approach is aimed at more efficiently tackling a wide array of diseases, potentially transforming the landscape of healthcare and pharmaceutical research.

Sponsored by:

To learn more about H1 please use the links below:

 Website  LinkedIn

To learn more about our guest and their company please use the links below:

Guest LinkedInCompany LinkedIn


Also, be sure to follow Slice of Healthcare on our social channels:

Website  – LinkedIn – Twitter – YouTube – Newsletter

More To Explore

Total
0
Share